Pharma Companies Turn to FDA for Social Media Guidance

The FDA’s “seeming lack of participation” regarding the development of social media guidelines has frustrated many in the affected communities. But pharma specialist Mark Senak says the recent influx of public comment submissions by pharma companies means the agency will soon face the challenge of “providing guidance that is broad enough to cover change.”

The Role of Digital Communications and ‘Pharmacovigilance’

In an article in PharmaVoice, pharma specialist Mark Senak discusses pharmacovigilance communication and explains why the best digital strategy includes “the concept of a two-way exchange.”

Read: Best Practices in Pharmacovigilance

Posted on February 3rd, 2012 | More Crisis Communications · Digital & Social Media · Healthcare
From News Feed to Lead: Three Facebook Areas Communicators Need to Know

Digital specialist Justin Goldsborough looks at three Facebook principles communicators must have a handle on, including an approach that’s “not sexy” but beats the “flash and sizzle.”

Posted on February 1st, 2012 | More B2C · Digital & Social Media
An Agenda for the 2012 Conventions

While political conventions are “networking on steroids,” they also provide serious business opportunities. The public affairs specialists at VOX Global, a Fleishman-Hillard company, share a strategy for engagement at the 2012 conventions.

Posted on January 31st, 2012 | More CSR · Digital & Social Media · Mobile · Public Affairs · Reputation Management